Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Immunology Année : 2022

Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

Dates et versions

hal-03652771 , version 1 (27-04-2022)

Identifiants

Citer

Yves Renaudineau, Florence Abravanel, Jacques Izopet, Chloé Bost, Emmanuel Treiner, et al.. Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response. Clinical Immunology, 2022, 237, pp.108979. ⟨10.1016/j.clim.2022.108979⟩. ⟨hal-03652771⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More